Skip to content

An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~

An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~ - An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038038
Enrollment
10
Registered
2020-03-31
Start date
2020-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia, respiratory syncytial virus infectious disease, human meta virus infectious diseases

Interventions

I carry out1cool RTX(clearance mode)between from 9:00 to 16:00. While I carry it out,I make abdominal position. 1)I perform the physique conversion in medical staff(doctor,nurse,physical ther apist)

Sponsors

Saitama Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The tracheal intubation patient who judged that I was hospitalized with a respiratory infectious disease (severe pneumonia, respiratory syncytial virus infectious disease, human meta virus infectious diseases), and a doctor needed abdominal position and the RTX (clearance mode) combination

Exclusion criteria

Exclusion criteria: The patient that an agreement was refused

Design outcomes

Primary

MeasureTime frame
[item evaluating abdominal position and an effect of RTX (clearance mode)] Data during an intubation period: I change the change of X-rays, blood test data, the instructions of the respiratory condition of it and compare the difference of data before and after the enforcement using mark order official approval of Wilcoxon belonging to in analysis during an intubation period [item evaluating safety] Presence of harm phenomena such as a flare of the skin with the practice, edema of the face, low blood pressure, tachycardia, the symptoms such as aspirations and accident extubation, tracheal intubation tube confinement by flexure and the secretion retention of the tracheal intubation tube, a tip status pulse route, an accident withdrawal or the flexure confinement of various drains

Secondary

MeasureTime frame
[item evaluating abdominal position and an effect of RTX (clearance mode)] 1)I investigate the days that I practiced from intubation day and the day when I introduced it 2)Basic data: Age of the patient, disease name, having underlying disease or not, the weight 3)Data before and after the enforcement of the patient: Vital signs, sedation depth (SBS), change of the amount of ventilation, change of change blood gas data of SpO2, EtCO2, 4)Data during an intubation period: I change the change of X-rays, blood test data, the instructions of the respiratory condition of it and compare the difference of data before and after the enforcement using mark order official approval of Wilcoxon belonging to in 3)analysis during an intubation period [item evaluating safety] 1)Presence of harm phenomena such as a flare of the skin with the practice, edema of the face, low blood pressure, tachycardia, the symptoms such as aspirations and accident extubation, tracheal intubation tube confinement by flexure and the secretion retention of the tracheal intubation tube, a tip status pulse route, an accident withdrawal or the flexure confinement of various drains

Countries

Japan

Contacts

Public ContactIppei Watanabe

Saitama Medical Center PICU

smcpicu@saitama-med.ac.jp049-228-3864

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026